Wall Street analysts expect that Owens & Minor, Inc. (NYSE:OMI) will post $2.45 billion in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Owens & Minor’s earnings. The lowest sales estimate is $2.40 billion and the highest is $2.53 billion. Owens & Minor posted sales of $2.37 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 3.4%. The company is scheduled to report its next quarterly earnings report on Tuesday, February 13th.

On average, analysts expect that Owens & Minor will report full-year sales of $2.45 billion for the current year, with estimates ranging from $9.33 billion to $9.46 billion. For the next year, analysts forecast that the firm will report sales of $10.31 billion per share, with estimates ranging from $10.08 billion to $10.48 billion. Zacks’ sales averages are an average based on a survey of research firms that cover Owens & Minor.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Wednesday, November 1st. The company reported $0.40 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.10). Owens & Minor had a return on equity of 10.85% and a net margin of 0.83%. The firm had revenue of $2.33 billion for the quarter, compared to analyst estimates of $2.40 billion. During the same period last year, the company earned $0.51 EPS. The company’s revenue was down 3.4% compared to the same quarter last year.

OMI has been the subject of several recent analyst reports. UBS AG reissued a “sell” rating and issued a $29.50 price objective (down previously from $30.50) on shares of Owens & Minor in a report on Thursday, August 3rd. Zacks Investment Research raised Owens & Minor from a “hold” rating to a “buy” rating and set a $34.00 price objective for the company in a report on Friday, August 4th. BidaskClub downgraded Owens & Minor from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Jefferies Group LLC reissued a “hold” rating and issued a $32.00 price objective (down previously from $36.00) on shares of Owens & Minor in a report on Wednesday, August 9th. Finally, Robert W. Baird raised Owens & Minor from an “underperform” rating to a “neutral” rating and set a $28.00 price objective for the company in a report on Friday, September 1st. Three research analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. Owens & Minor has a consensus rating of “Hold” and an average price target of $27.25.

A number of hedge funds have recently bought and sold shares of the business. Isthmus Partners LLC increased its position in Owens & Minor by 0.4% during the 2nd quarter. Isthmus Partners LLC now owns 17,425 shares of the company’s stock worth $561,000 after buying an additional 74 shares during the period. Blair William & Co. IL increased its position in Owens & Minor by 0.5% during the 2nd quarter. Blair William & Co. IL now owns 20,638 shares of the company’s stock worth $664,000 after buying an additional 97 shares during the period. Creative Planning increased its position in Owens & Minor by 2.9% during the 2nd quarter. Creative Planning now owns 4,021 shares of the company’s stock worth $129,000 after buying an additional 113 shares during the period. Security National Bank of Sioux City Iowa IA increased its position in Owens & Minor by 1.4% during the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 18,871 shares of the company’s stock worth $607,000 after buying an additional 267 shares during the period. Finally, Northwestern Mutual Investment Management Company LLC increased its position in Owens & Minor by 3.1% during the 2nd quarter. Northwestern Mutual Investment Management Company LLC now owns 10,840 shares of the company’s stock worth $405,000 after buying an additional 321 shares during the period. Hedge funds and other institutional investors own 97.10% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/11/22/analysts-anticipate-owens-minor-inc-omi-will-post-quarterly-sales-of-2-45-billion.html.

Owens & Minor (NYSE:OMI) opened at $18.40 on Wednesday. Owens & Minor has a 12-month low of $17.75 and a 12-month high of $37.02. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.95 and a current ratio of 1.77. The firm has a market capitalization of $1,110.00, a P/E ratio of 10.88, a price-to-earnings-growth ratio of 2.05 and a beta of 0.97.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be paid a $0.2575 dividend. This represents a $1.03 dividend on an annualized basis and a yield of 5.60%. The ex-dividend date of this dividend is Thursday, December 14th. Owens & Minor’s dividend payout ratio (DPR) is presently 81.75%.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Get a free copy of the Zacks research report on Owens & Minor (OMI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related companies with MarketBeat.com's FREE daily email newsletter.